Apolipoprotein E (APOE) ε4 homozygosity, a strong risk factor for AD, was also suggested a potent predictor of cognitive decline in patients with early relapse-remitting MS (Engel et al., 2020). This evidence concerns the gene APOE and myeloid sarcoma.